State of Michigan Retirement System Has $18.88 Million Stock Holdings in HCA Healthcare, Inc. $HCA

State of Michigan Retirement System lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 5.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 44,309 shares of the company’s stock after selling 2,800 shares during the period. State of Michigan Retirement System’s holdings in HCA Healthcare were worth $18,884,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Bessemer Group Inc. grew its position in HCA Healthcare by 19.0% in the 3rd quarter. Bessemer Group Inc. now owns 3,364 shares of the company’s stock valued at $1,434,000 after purchasing an additional 536 shares during the period. Triglav Investments D.O.O. bought a new stake in shares of HCA Healthcare during the third quarter worth about $852,000. Optimize Financial Inc bought a new position in HCA Healthcare in the 3rd quarter valued at about $430,000. Savant Capital LLC increased its holdings in HCA Healthcare by 37.7% during the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares in the last quarter. Finally, Westside Investment Management Inc. boosted its position in shares of HCA Healthcare by 17.7% during the third quarter. Westside Investment Management Inc. now owns 413 shares of the company’s stock valued at $176,000 after buying an additional 62 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on HCA shares. Truist Financial raised their price objective on HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Leerink Partners upped their price objective on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. The Goldman Sachs Group lifted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Finally, Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research report on Monday, December 15th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $521.55.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $501.89 on Friday. The stock has a market capitalization of $114.53 billion, a P/E ratio of 17.68, a P/E/G ratio of 1.54 and a beta of 1.36. The stock’s 50-day simple moving average is $479.97 and its 200 day simple moving average is $442.72. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $527.55.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the prior year, the company posted $6.22 EPS. HCA Healthcare’s revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.99%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.